Co-administration of JQ1, a bromodomain-containing protein 4 inhibitor, enhances the antitumor effect of combretastatin A4, a microtubule inhibitor, while attenuating its cardiotoxicity.
Biomed Pharmacother
; 160: 114353, 2023 Apr.
Article
en En
| MEDLINE
| ID: mdl-36736274
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Estilbenos
/
Factores de Transcripción
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Biomed Pharmacother
Año:
2023
Tipo del documento:
Article